Literature DB >> 6302176

Adenovirus type 7b in a children's hospital.

R C Straube, M A Thompson, R B Van Dyke, G Wadell, J D Connor, D Wingard, S A Spector.   

Abstract

Between August 15 and September 15, 1980, an outbreak of infections due to adenovirus type 7b occurred at Children's Hospital and Health Center, San Diego, California. During that time, four of six patients infected with adenovirus type 7b died. All patients with hospital-acquired disease had underlying respiratory compromise. Cultures, adenoviral serology tests, and histories were obtained from 383 (93%) of the 410 hospital employees. All 11 people from whom adenovirus type 7 was cultured were nurses working in a unit with an infected patient. Seven other employees with negative cultures had a fourfold or greater rise in their adenoviral complement fixation titers. This outbreak demonstrates that adenovirus type 7 infections are capable of causing serious and potentially fatal disease in hospitalized patients and suggests that individuals with underlying respiratory diseases are especially at risk.

Entities:  

Mesh:

Year:  1983        PMID: 6302176     DOI: 10.1093/infdis/147.5.814

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Molecular epidemiology and restriction site mapping of adenovirus 7 genome types.

Authors:  T Adrian; M Becker; J C Hierholzer; R Wigand
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

2.  Comparison of neutralization and DNA restriction enzyme methods for typing clinical isolates of human adenovirus.

Authors:  K H Fife; R Ashley; A F Shields; D Salter; J D Meyers; L Corey
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

Review 3.  The risk of infection in anaesthetic practice.

Authors:  W F Schlech
Journal:  Can J Anaesth       Date:  1988-05       Impact factor: 5.063

4.  Genomic variation of adenovirus type 5 isolates recovered from bone marrow transplant recipients.

Authors:  D H Webb; A F Shields; K H Fife
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

5.  Isolation and characterization of six new genome types of human adenovirus types 1 and 2.

Authors:  K H Fife; R Ashley; L Corey
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948

6.  Human adenovirus type 7 infection associated with severe and fatal acute lower respiratory illness and nosocomial transmission.

Authors:  Xianyan Cui; Liang Wen; Zhihao Wu; Nan Liu; Chaojie Yang; Wei Liu; Zhongwei Ba; Jian Wang; Shengjie Yi; Hao Li; Beibei Liang; Peng Li; Leili Jia; Rongzhang Hao; Ligui Wang; Yuejin Hua; Yong Wang; Shaofu Qiu; Hongbin Song
Journal:  J Clin Microbiol       Date:  2014-12-17       Impact factor: 5.948

7.  Virology and infection control.

Authors:  William M Valenti
Journal:  Clin Microbiol Newsl       Date:  2007-01-17

Review 8.  Molecular epidemiology of adenovirus type 7 in the United States, 1966-2000.

Authors:  Dean D Erdman; Wanhong Xu; Susan I Gerber; Gregory C Gray; David Schnurr; Adriana E Kajon; Larry J Anderson
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

9.  Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004.

Authors:  Kevin L Russell; Anthony W Hawksworth; Margaret A K Ryan; Jennifer Strickler; Marina Irvine; Christian J Hansen; Gregory C Gray; Joel C Gaydos
Journal:  Vaccine       Date:  2006-01-24       Impact factor: 3.641

10.  Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006.

Authors:  Gregory C Gray; Troy McCarthy; Mark G Lebeck; David P Schnurr; Kevin L Russell; Adriana E Kajon; Marie L Landry; Diane S Leland; Gregory A Storch; Christine C Ginocchio; Christine C Robinson; Gail J Demmler; Michael A Saubolle; Sue C Kehl; Rangaraj Selvarangan; Melissa B Miller; James D Chappell; Danielle M Zerr; Deanna L Kiska; Diane C Halstead; Ana W Capuano; Sharon F Setterquist; Margaret L Chorazy; Jeffrey D Dawson; Dean D Erdman
Journal:  Clin Infect Dis       Date:  2007-09-27       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.